After WHO request, DGCI gives nod to export of SII-made Ebola vaccine to Uganda
- The vaccine is developed by the Serum Institute of India (SII) in collaboration with Oxford University in the United Kingdom
After the World Health Organisation (WHO) sought collaboration to fight Ebola, India's first vaccine for the disease manufactured by the Serum Institute of India (SII) is approved for export to Uganda by the Drugs Controller General of India.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more